• Brazil

in page functions
  • Brazil flag

  • Contributions and pledges over time (US$ millions)

     

    Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
     

    Notes:
    Direct Contributions (including Matching Fund)
    Received contributions: non-US$ contributions for 2000-2016 and Q1-Q2 2017are expressed in US$ equivalents using the exchange rates on the dates of receipt.  For 2014, 2015, 2016 and Q1-Q2 2017, where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.

    Future contributions: non-US$ Direct Contribution and Matching Fund pledges for Q3-Q4 2017 and years 2018 and beyond are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 30 June 2017 or using the rates applicable to any hedge agreement in place.

    IFFIm contributions
    Received contributions: non-US$ contributions for 2000-2016 are expressed in US$ equivalents as confirmed by the IBRD (World Bank).

    Future contributions: non-US$ contributions are expressed in US$ equivalents as follows:

    • Where the contribution agreement has been signed: contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements
    • Where the contribution agreement has not yet been signed: non-US$ pledges for years 2017 and beyond are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 30 June 2017
    • These contributions have not been reduced by a notional 3% provision to allow for any potential reduction arising from the High Level Financing Condition of the IFFIm Finance Framework Agreement.

     

  • Funding history

    Brazil has an increasing role as a political and economic actor in developed and developing countries. Brazil has a long standing commitment to ensuring access to medicines and vaccines at the domestic, regional and international level. The Ministry of Health strategy for 2012-2015 addresses 5 pillars. These include the promotion of Brazil’s science and technology complex; Brazilian presence in multilateral health forums; strengthening of regional health integration; strengthening of international humanitarian health support; improved management of Brazilian engagement in international health issues. Brazil’s state owned vaccine manufacturer Bio-Manguinhos is a supplier of yellow fever vaccine to Gavi.

    In 2006, Brazil pledged USD 20 million over 20 years to IFFIm. Legislative approval was granted by Congress on 31 May 2011 to allow Brazil to make contributions to Gavi. Brazil is currently finalising the pledge agreement.

    Contributions and pledges in total:

    • IFFIm: USD 20 million over 20 years.
close icon

modal window here